Gradiant DarkLight Background

XO SCORE® AND XO CROSS® 

ARE FDA AND CE MARK CLEARED

XO Score Critical.png
XOS logo black Space.png

Critical Venous Outflow Stenosis in Hemodialysis Fistula

Background Texture
Gradient Background
XO Score Logo
Home Page Score_Image.png
A market-first, ultra-low-profile, metal alloy scoring sheath designed to convert off-the-shelf PTA balloon catheters into scoring and infusion systems.
XO Cross Logo
Home Page Cross_Image.png
Ultra-low-profile one-piece metal alloy micro and support catheters
that deliver class-leading performance and specs. 

TARGET TREATMENT & APPLICATIONS

Leg Artery Diagram

PERIPHERAL ARTERY DISEASE (PAD)

Increasingly complex interventions and advanced PAD disease states in require novel technologies and tools to improve the quality of care for patients. The XO Score and XO Cross platforms have been designed and optimized for dilatation and access of tough calcified lesions in the peripheral vasculature.

Arm Artery Diagram

END-STAGE RENAL DISEASE (ESRD)

A high rate of arteriovenous fistulas and grafts fail due to excessive intimal hyperplasia-related stenoses. Dialysis interventions often require extreme high-pressure angioplasty to salvage access sites and restore flow. XO Score was designed to effectively dilatate tough, fibrous lesions encountered during fistula and graft maintenance.

Gray Background

LATEST NEWS

Cath Lab Digest
Calender

November 11, 2022

Posted on 

FDA Clears Angioplasty Platform to Crack, Break, and Dilate Stenosis in Calcified Cardiovascular Disease and Hemodialysis Fistula
Vascular News
Calender

November 11, 2022

Posted on 

Transit Scientific announces US FDA clearance for XO RX angioplasty platform
Endovascular Today
Calender

November 11, 2022

Posted on 

Transit Scientific’s XO RX 2.2 and 3.8 F Rapid Exchange PTA Devices Cleared by FDA
Cath Lab Digest
Calender

August 15, 2022

Posted on 

Additional Patent Protection For Exoskeleton Focal-Force Angioplasty Platform Granted by the U.S. Patent Office

The XO Score® Sheath Platform is FDA 510(k) and CE Mark cleared to be used in conjunction with a PTA balloon to facilitate dilation and apposition of the scoring surface to the stenotic material in the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries; and for treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. Not for use in the coronary or neuro-vasculature. The XO Cross® Catheter Platform is also FDA 510(k) and CE Mark cleared to be used to guide and support a guidewire during access of the peripheral vasculature, allow for wire exchanges and provide a conduit for the delivery of saline solutions or diagnostic contrast agents.